Patrick Ryan

Процитировано

	Все	Начиная с 2020 г.
Статистика цитирования	15290	10813
h-индекс	61	52
i10-индекс	200	171

2300

1150

575

1725

20122013201420152016201720182019202020212022202320242025131 325 382 447 490 551 785 1015 1525 2178 2207 2171 2233 472

Общий доступ

Просмотреть все

174 статьи

15 статей

доступно

недоступно

На основе финансирования

Соавторы

Martijn SchuemieJanssen R&DПодтвержден адрес электронной почты в домене ohdsi.org
George HripcsakColumbia UniversityПодтвержден адрес электронной почты в домене columbia.edu
Marc A. SuchardProfessor, University of California, Los AngelesПодтвержден адрес электронной почты в домене ucla.edu
David MadiganProfessor of Statistics, Northeastern UniversityПодтвержден адрес электронной почты в домене northeastern.edu
Rae Woong ParkProfessor of Department of Biomedical Informatics, Ajou University School of MedicineПодтвержден адрес электронной почты в домене ajou.ac.kr
Nigam ShahProfessor of Medicine, and Biomedical Data Science, Stanford UniversityПодтвержден адрес электронной почты в домене stanford.edu
J. Marc OverhageThe Overhage GroupПодтвержден адрес электронной почты в домене overhagegroup.com
Frank J DeFalcoJanssen Research & DevelopmentПодтвержден адрес электронной почты в домене its.jnj.com
Chunhua WengProfessor, Columbia UniversityПодтвержден адрес электронной почты в домене columbia.edu
Jesse A BerlinVP, Epidemiology, Janssen Research and DevelopmentПодтвержден адрес электронной почты в домене its.jnj.com
Erica A VossJanssen Research & DevelopmentПодтвержден адрес электронной почты в домене its.jnj.com
Nicholas P TatonettiProfessor and Vice Chair of Computational Biomedicine, Cedars-Sinai Medical CenterПодтвержден адрес электронной почты в домене cshs.org
Rave HarpazArchitect/Applied Scientist of AI - Oracle Cloud InfrastructureПодтвержден адрес электронной почты в домене oracle.com
Niklas NorénChief Science Officer, Uppsala Monitoring Centre, WHO Collaborating Centre for International DrugПодтвержден адрес электронной почты в домене who-umc.org
M. Soledad CepedaJanssen Research & DevelopmentПодтвержден адрес электронной почты в домене its.jnj.com
Qianli MaResearch Science Lead, HumanaПодтвержден адрес электронной почты в домене humana.com
Richard D BoyceAssociate Professor of Biomedical Informatics, University of PittsburghПодтвержден адрес электронной почты в домене pitt.edu
Shawn E. SimpsonColumbia UniversityПодтвержден адрес электронной почты в домене stat.columbia.edu
Paea LePenduUniversity of California, RiversideПодтвержден адрес электронной почты в домене ucr.edu
Andrew BateGSK, LSHTMПодтвержден адрес электронной почты в домене gsk.com

Patrick Ryan

Janssen Research and Development

Подтвержден адрес электронной почты в домене cornell.edu

Pharmacovigilance Epidemiology Statistics Medical Informatics


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ... MEDINFO 2015: eHealth-enabled Health, 574-578, 2015	1317	2015
Validation of a common data model for active safety surveillance research JM Overhage, PB Ryan, CG Reich, AG Hartzema, PE Stang Journal of the American Medical Informatics Association 19 (1), 54-60, 2012	549	2012
A harmonized data quality assessment terminology and framework for the secondary use of electronic health record data MG Kahn, TJ Callahan, J Barnard, AE Bauck, J Brown, BN Davidson, ... Egems 4 (1), 1244, 2016	512	2016
Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership PE Stang, PB Ryan, JA Racoosin, JM Overhage, AG Hartzema, C Reich, ... Annals of internal medicine 153 (9), 600-606, 2010	482	2010
Novel data‐mining methodologies for adverse drug event discovery and analysis R Harpaz, W DuMouchel, NH Shah, D Madigan, P Ryan, C Friedman Clinical Pharmacology & Therapeutics 91 (6), 1010-1021, 2012	450	2012
Characterizing treatment pathways at scale using the OHDSI network G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ... Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016	369	2016
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis MA Suchard, MJ Schuemie, HM Krumholz, SC You, RJ Chen, N Pratt, ... The Lancet 394 (10211), 1816-1826, 2019	351	2019
Performance of pharmacovigilance signal‐detection algorithms for the FDA adverse event reporting system R Harpaz, W DuMouchel, P LePendu, A Bauer‐Mehren, P Ryan, ... Clinical Pharmacology & Therapeutics 93 (6), 539-546, 2013	341	2013
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ... Journal of the American Medical Informatics Association 22 (3), 553-564, 2015	314	2015
Feasibility of using real-world data to replicate clinical trial evidence VL Bartlett, SS Dhruva, ND Shah, P Ryan, JS Ross JAMA network open 2 (10), e1912869-e1912869, 2019	236	2019
Interpreting observational studies: why empirical calibration is needed to correct p‐values MJ Schuemie, PB Ryan, W DuMouchel, MA Suchard, D Madigan Statistics in medicine 33 (2), 209-218, 2014	236	2014
A curated and standardized adverse drug event resource to accelerate drug safety research JM Banda, L Evans, RS Vanguri, NP Tatonetti, PB Ryan, NH Shah Scientific data 3 (1), 1-11, 2016	235	2016
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 … PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ... Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018	222	2018
Design and implementation of a standardized framework to generate and evaluate patient-level prediction models using observational healthcare data JM Reps, MJ Schuemie, MA Suchard, PB Ryan, PR Rijnbeek Journal of the American Medical Informatics Association 25 (8), 969-975, 2018	216	2018
Evaluating the impact of database heterogeneity on observational study results D Madigan, PB Ryan, M Schuemie, PE Stang, JM Overhage, ... American journal of epidemiology 178 (4), 645-651, 2013	205	2013
Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership PB Ryan, D Madigan, PE Stang, J Marc Overhage, JA Racoosin, ... Statistics in medicine 31 (30), 4401-4415, 2012	199	2012
Challenges with quality of race and ethnicity data in observational databases FCG Polubriaginof, P Ryan, H Salmasian, AW Shapiro, A Perotte, ... Journal of the American Medical Informatics Association 26 (8-9), 730-736, 2019	183	2019
Criteria2Query: a natural language interface to clinical databases for cohort definition C Yuan, PB Ryan, C Ta, Y Guo, Z Li, J Hardin, R Makadia, P Jin, N Shang, ... Journal of the American Medical Informatics Association 26 (4), 294-305, 2019	174	2019
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020	173	2020
Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study X Li, A Ostropolets, R Makadia, A Shoaibi, G Rao, AG Sena, ... bmj 373, 2021	164	2021

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы